Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
The Journal of Experimental Medicine|March 1, 1991
Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactionsP F Piguet, G E Grau, C Hauser, et al.
European Cytokine Network|September 1, 1993
Stabilisation of functional tumor necrosis factor-alpha by its soluble TNF receptorsD De Groote, G E Grau, I Dehart, et al.
The Journal of Experimental Medicine|November 1, 1987
Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host diseaseP F Piguet, G E Grau, B Allet, et al.
The Journal of Experimental Medicine|March 1, 1983
Induction of acute thrombocytopenia and infection of megakaryocytes by Rauscher murine leukemia virus reflect the genetic susceptibility to leukemogenesisG E Grau, P Puthavathana, S Izui, et al.
European Journal of Immunology|December 1, 1996
Direct cell/cell contact with stimulated T lymphocytes induces the expression of cell adhesion molecules and cytokines by human brain microvascular endothelial cellsJ Lou, J M Dayer, G E Grau, et al.
The American Review of Respiratory Disease|February 1, 1993
Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD-11 antibodiesP F Piguet, H Rosen, C Vesin, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|October 29, 2003
[Pathogenesis of cerebral malaria: facts and hypotheses]S C Wassmer, N Coltel, V Combes, et al.
The Journal of Investigative Dermatology|June 1, 1994
Protective effect of N-acetylcysteine in hapten-induced irritant and contact hypersensitivity reactionsG Senaldi, P Pointaire, P F Piguet, et al.
Circulatory Shock|January 1, 1994
Early hemodynamic and renal effects of tumor necrosis factor alpha: role of thromboxaneE Girardin, G E Grau, L Paunier, et al.
The American Journal of Tropical Medicine and Hygiene|March 21, 1998
Demonstration of anti-disease immunity to Plasmodium vivax malaria in Sri Lanka using a quantitative method to assess clinical diseaseN D Karunaweera, R Carter, G E Grau, et al.
Pageof 14